Cor Vasa 2017, 59(3):e246-e250 | DOI: 10.1016/j.crvasa.2016.10.005
Increased maximum p wave duration in smoking patients with ST-elevation acute myocardial infarction and its relationship with inflammatory markers
- a Servicio de Cardiología, Hospital Universitario Celestino Hernández Robau, Santa Clara, Villa Clara, Cuba
- b Departamento de Electrofisiología y Estimulación Cardíaca, Cardiocentro Ernesto Che Guevara, Santa Clara, Villa Clara, Cuba
- c Servicio de Terapia Intensiva, Hospital Universitario Celestino Hernández Robau, Santa Clara, Villa Clara, Cuba
Introduction: Electrocardiographic markers for atrial fibrillation and the relationship with inflammatory markers have not been evaluated in smoker patients with acute myocardial infarction.
Material and methods: This is a cross-sectional study developed between January 2012 and July 2014 at Hospital Universitario Celestino Hernández Robau from Santa Clara, Cuba. One hundred fifteen patients were included finally. The sample was divided into two groups (smokers and non-smokers). We obtained clinical and laboratory data and compared electrocardiographic markers for atrial fibrillation in both groups and with inflammatory markers.
Results: Maximum p wave duration was significantly higher in smoker than non-smoker patients (102 ± 12 vs. 97 ± 9; p = 0.020). Minimum p wave duration and p wave dispersion also are higher in smoker patients but not significantly (61 ± 10 vs. 60 ± 7; p = 0.476 and 41 ± 10 vs. 37 ± 9; p = 0.050). There is a positive and significant linear correlation between neutrophils count and maximum p wave duration in smokers (r = 0.45; p = 0.004), but not in non-smokers patients (r = 0.09; p = 0.49). There is a negative correlation between lymphocyte count and maximum p wave duration in smokers (r = -0.44; p = 0.004) and in non-smoker patients (r = -0.07; p = 0.62).
Conclusion: Maximum p wave duration is higher in smoker patients than non-smoker patients during ST-elevation acute myocardial infarction. Neutrophil count is positively associated with maximum p wave duration in smoker patients. Lymphocyte count has a negative association with maximum p wave duration.
Keywords: Acute myocardial infarction; Atrial fibrillation; Inflammatory markers; p wave dispersion; p wave duration; Smoking
Received: May 12, 2016; Revised: October 21, 2016; Accepted: October 24, 2016; Published: June 1, 2017 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- G. Lip, H.F. Tse, D.A. Lane, Atrial fibrillation, Lancet 379 (2012) 648-661.
Go to original source...
Go to PubMed...
- S.S. Chugh, R. Havmoeller, K. Narayanan, et al., Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study, Circulation 129 (2014) 837-847.
Go to original source...
Go to PubMed...
- C.T. January, L.S. Wann, J.S Alpert, et al., 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, Journal of the American College of Cardiology 64 (2014) e1-e76.
Go to original source...
Go to PubMed...
- I.E. Albertsen, T.F. Overvad, G.Y. Lip, T.B. Larsen, Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics, Current Opinion in Cardiology 30 (2015) 512-517.
Go to original source...
Go to PubMed...
- D.G. Yanbaeva, M.A. Dentener, E.C. Creutzberg, et al., Systemic effects of smoking, Chest 131 (2007) 1557-1566.
Go to original source...
Go to PubMed...
- S.S. Rathore, A.K. Berger, K.P. Weinfurt, et al., Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes, Circulation 101 (2000) 969-974.
Go to original source...
Go to PubMed...
- S.A. Lubitz, J.W. Magnani, P.T. Ellinor, et al., Atrial fibrillation and death after myocardial infarction. Risk marker or causal mediator? Circulation 123 (2011) 2063-2065.
Go to original source...
Go to PubMed...
- J.W. Magnani, V.M. Johnson, L.M. Sullivan, et al., P wave duration and risk of longitudinal atrial fibrillation risk in persons ≥ 60 years old (from the Framingham Heart Study), American Journal of Cardiology 107 (2011) 917-921.
Go to original source...
Go to PubMed...
- I.C. Chang, E. Austin, B. Krishnan, Shorter minimum P-wave duration is associated with paroxysmal lone atrial fibrillation, Journal of Electrocardiology 47 (2014) 106-112.
Go to original source...
Go to PubMed...
- L.G. Tereshchenko, C.A. Henrikson, N. Sotoodehnia, et al., Electrocardiographic deep terminal negativity of the P wave in V1 and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) Study, Journal of the American Heart Association 3 (2014) e001387.
Go to original source...
Go to PubMed...
- T. Yamada, M. Fukunami, M. Shimonagata, et al., Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation, European Heart Journal 20 (1999) 211-220.
Go to original source...
Go to PubMed...
- J.B. Nielsen, J.T. Kühl, A. Pietersen, et al., P-wave duration and the risk of atrial fibrillation: results from the Copenhagen ECG Study, Heart Rhythm (2015) 1-9.
Go to original source...
- J. Heeringa, J.A. Kors, A. Hofman, et al., Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study, American Heart Journal 156 (2008) 1163-1169.
Go to original source...
Go to PubMed...
- A.M. Chamberlain, S.K. Agarwal, A.R. Folsom, et al., Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study, Heart Rhythm 8 (2011) 1160-1166.
Go to original source...
Go to PubMed...
- A. Goette, U. Lendeckel, A. Kuchenbecker, et al., Cigarette smoking induces atrial fibrosis in humans via nicotine, Heart 93 (2007) 1056-1063.
Go to original source...
Go to PubMed...
- A. Goette, Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke? Cardiovascular Research 83 (2009) 421-422.
Go to original source...
Go to PubMed...
- S.M. Green, J. Vowels, B. Waterman, et al., Leukocytosis: a new look at an old marker for acute myocardial infarction, Academic Emergency Medicine 3 (1996) 1034-1041.
Go to original source...
Go to PubMed...
- Z. Li, L. Cui, J. Ma, et al., Association between neutrophil to lymphocyte ratio and atrial fibrillation, International Journal of Cardiology 187 (2015) 361-362.
Go to original source...
Go to PubMed...
- A.J. Kirtane, A. Bui, S.A. Murphy, et al., Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction, American Journal of Cardiology 93 (2004) 532-536.
Go to original source...
Go to PubMed...
- D. Tousoulis, C. Antoniades, N. Koumallos, C. Stefanadis, Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside, Cytokine and Growth Factor Reviews 17 (2006) 225-233.
Go to original source...
Go to PubMed...
- A. Widmer, A.Z. Linka, C.H. Attenhofer Jost, et al., Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia, Cardiology 99 (2003) 25-31.
Go to original source...
Go to PubMed...
- Y.C. Han, T.H. Yang, D.I.I. Kim, et al., Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, Korean Circulation Journal 43 (2013) 93-99.
Go to original source...
Go to PubMed...
- S. Ghaffari, M. Nadiri, L. Pourafkari, et al., The predictive value of total neutrophil count and neutrophil/lymphocyte ratio in predicting in-hospital mortality and complications after STEMI, Journal of Cardiovascular and Thoracic Research 6 (2014) 35-41.
Go to original source...
Go to PubMed...